The University of Notre Dame and the Indiana Biosciences Research Institute (IBRI) have signed a strategic alliance agreement to encourage collaborations between Notre Dame and IBRI researchers.

In a new study published in the Journal of Experimental Medicine, scientists at the University of Notre Dame have discovered that the pathogen Mycobacterium tuberculosis (MTB) releases RNA into infected cells.

COSE-JAM highlights the achievements of graduate students and postdoctoral trainees. The event helps them foster interdisciplinary research and interactions, develop presentation and mentoring skills, and obtain advice on career development.

Faculty are now invited to apply for awards within the Notre Dame Research Internal Grants Program. The deadline to apply to the available grants is Monday, February 4, 2019 at 5:00 p.m. EST.

Mark Fraser, MD/PhD student through the IU School of Medicine and the University of Notre Dame, member of the Lee Lab, and recent Eck Institute for Global Health Fellow, discusses his area of research and experiences in the Master of Science of Global Health program.

Mark your calendars! Rare Disease Day 2019 will be held on March 1st and 2nd, 2019.  More information to follow…   Originally published…

Pinar Zorlutuna, Associate Professor in the College of Engineering and affiliated member of the Center for Stem Cells and Regenerative Medicine,…

Siyuan Zhang, the Dee Associate Professor of Biological Sciences who is also affiliated with the Harper Cancer Research Institute, landed a nearly $1.1 million Breast Cancer Research Program Breakthrough Award through the Department of Defense in August.

The University of Notre Dame has opened its annual competition for the Naughton Fellowships. The prestigious international fellowships provide funding for exceptional students with an aptitude for the STEM disciplines to complete research or study in Ireland or at Notre Dame (ND).

From Saturday, October 28 through Thursday, November 1, members of the University of Notre Dame research community will travel to New Orleans, LA for the annual American Society of Tropical Medicine and Hygiene (ASTMH) meeting. Of the over 40 Notre Dame faculty, researchers, and students in attendance, many will be...

Guido Camargo España, postdoctoral research associate of biological sciences, has received a Postdoctoral Training Award inTranslational Research from the Indiana Clinical and Translational Sciences Institute (CTSI).

What role can Notre Dame play in the revolution building around rare disease research? A collaborative team of stakeholders discussed different options during a working session in October.

Xin Lu, the John M. and Mary Jo Boler Assistant Professor of biology, was awarded a 2018 Susan G. Komen research grant to identify potential new therapies for treating metastatic breast cancer.

Submission Deadline: Dec 10th, 2018 5:00 PM Earliest Start Date. March 1, 2019.   …

Predicting how mutations in proteins alter their ability to function is critical to understanding what drives health and disease in humans. A new study in Structure, Cell Press by scientists at the University of Notre Dame and their colleagues demonstrates how a minor mutation can have far-reaching effects on a...

Perlara, a rare diseases drug discovery company based in the San Francisco Bay area, recently announced a collaboration called PerlQuest with the University of Notre Dame’s Warren Family Research Center for Drug Discovery and Development.

University of Notre Dame doctoral and thesis master’s students can now apply for the Rapid Exposure to Advanced Computational Training (REACT) program.

 

Indiana University, Purdue University, and the University of Notre Dame invite all researchers to attend the Indiana Clinical and Translational Sciences Institute (CTSI) retreat. The event will take place at the University of Notre Dame’s McCourtney Hall on Friday, October 26, 2018 from 9:00 a.m. to 4:15 p.m.

The discovery made by Notre Dame researchers and their collaborators tosses a new wrench into the process of building better molecules to develop immunotherapies.

Seven University of Notre Dame graduate students have successfully received fellowships from the Eck Institute for Global Health.

The Walther Foundation has made a $3.5 million matching-fund gift that it hopes will inspire those with a similar passion to support novel, multidisciplinary approaches to cancer research.

September is National Ovarian Cancer Awareness month.  Many of us will wear the color teal in the form of ribbons, wristbands, headscarves and other gear in support of women with…

Presenting at the 7th Annual Harper Cancer Research Day L to R: Daniel Hogan, Marissa Koscielski, Juan Cisneros, Claire Kleinschmidt, Brady Riesgraf, Cian O’Donnell …

Each year, grants from the Discovery Fund are awarded to researchers who propose novel technologies and diagnostics that can improve human and environmental health.

All full-time, regular faculty are encouraged to apply for the Faculty Research Support Program (FRSP) Regular Grant, the FRSP Initiation Grant, and the Francis M. Kobayashi Travel Fund (KTF).

Norman Dovichi, the Grace-Rupley Professor of Chemistry and Biochemistry, is the recipient of the inaugural College of Science Research Award.

Nora J. Besansky, the O'Hara Professor and Associate Chair in the Department of Biological Sciences, hypothesizes in a recent paper in the Proceedings of the National Academy of Sciences that if scientists can understand what makes a small group of Anopheles mosquito a strong malaria vector, then perhaps we can prevent the...

The Research Like A Champion (RLAC) Program is offering $12,500 to any and all students who are interested in cancer research. For those of you who are not familiar with the RLAC Program, it is a collaborative effort within the …

The β-lactams are a vast family of antibiotics that include the well-known penicillins; they remain the most widely administered antibiotics around the globe.  Results from this research could reveal new strategies for coping with the expanding scope of β-lactam resistance now happening among Gram-negative pathogens.